Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma
Neuroblastoma is one of the few childhood cancers that carries a tumor-specific antigen in the form of a glycolipid antigen known as GD2. It has restricted expression in normal tissue, such as peripheral afferent nerves. Monoclonal antibodies targeting GD2 have been applied clinically to high-risk n...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2022-02-01
|
| Edice: | Biomolecules |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2218-273X/12/3/358 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|